Toxicity testing, systematic

As in many countries, the first attempts at understanding the effects of pollution on aquatic ecosystems in Argentina began within the academic and scientific community [191]. A systematic approach using toxicity tests with aquatic organisms is applied only in scientific laboratories. 

Environmental contaminants are present as complex mixtures, so that if toxicity is found, procedures known as toxicity identification evaluation may be carried out. This procedure identifies toxic components by systematically treating the effluent, elutrate, or pore water to remove various fractions - hydro-phobic ( fat soluble ) chemicals, metals, acids, volatile compounds, etc. - and retesting the toxicity after each extraction. Loss of toxicity after an extraction implicates the chemical that was extracted. This is confirmed by chemical analysis and toxicity tests on... 

The movement toward systematic formalized toxicity testing began, as might be expected, with the problem of chemicals in foods in the 1940 s. A Food and Drug Administration report published in 1943 (4 ) offered some general protocols. As additional toxic effecfT-- unsuspected at that time -- became known, these rec-... 

We believe that it will also stimulate progress in the systematic development of DNA biosensors and their application as screening tools for drug investigation, as warning systems in rapid chemical toxicity tests, as testing devices in food and water analysis, in the evaluation of effects of antioxidants, and in the investigation of interactions of nucleic acids with other biomacromolecules as proteins. 

The biological test result reflects a systematic error. This can be a difference between a nominal and an actual test concentration as a result of loss of the chemical through volatilization during the test. Fish toxicity test results performed on volatile chemicals are subject to this type of problem. 

The Nanotechnology Characterization Laboratory (NCL) of the National Cancer Institute (NCI) [3] has recently started publishing standards for nanomedicine and the toxicity testing of nanomaterials. The intention is to develop a set of characterisation protocols that can be used in research laboratories to assess toxicity. The testing will, as a consequence, be carried out under similar conditions, making it possible to compare different nanoparticle systems and obtain a systematic imderstanding of their in vivo and in vitro effects. 

For many years the usual procedure in plant design was to identify the hazards, by one of the systematic techniques described later or by waiting until an accident occurred, and then add on protec tive equipment to control future accidents or protect people from their consequences. This protective equipment is often complex and expensive and requires regular testing and maintenance. It often interferes with the smooth operation of the plant and is sometimes bypassed. Gradually the industry came to resize that, whenever possible, one should design user-friendly plants which can withstand human error and equipment failure without serious effects on safety (and output and emciency). When we handle flammable, explosive, toxic, or corrosive materials we can tolerate only very low failure rates, of people and equipment—rates which it may be impossible or impracticable to achieve consistently for long periods of time. 

Step 1 Cytotoxicity. Each polymer was evaluated, at least twice, in blind experiments, according to their toxicity toward insulinoma cells. For many polymers alternative suppliers and molecular weights were also tested. In total 37 polyanions were obtained of which 23 were systematically evaluated. By comparison, 29 of the 36 polycations procured were systematically tested. The results of these experiments are provided in Table 4. 

Is there sufficient systematic toxicity data available at levels that demonstrate adequate exposure If a study was designed such that there was insufficient exposure or duration of exposure to potential lymphoid target tissues, the test protocol may not be adequate to demonstrate an adverse effect. 

The work on the toxicity of nanoparticular reporters is still in its infancy. The clear evaluation of cytotoxicity will require verified data using at least two or more independent test systems, standardization in the experimental set-up and exposure conditions in order to be reliable. In addition, the involvement of toxicologists in the systematic assessment of QD toxicity would be beneficial. 

---